- Home
- MDAI vs CVM Comparison
MDAI vs CVM Comparison
Compare MDAI & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDAI
- CVM
- Stock Information
- Founded
- MDAI 2013
- CVM 1983
- Country
- MDAI United States
- CVM United States
- Employees
- MDAI N/A
- CVM N/A
- Industry
- MDAI Medical/Dental Instruments
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MDAI Health Care
- CVM Health Care
- Exchange
- MDAI Nasdaq
- CVM Nasdaq
- Market Cap
- MDAI 51.9M
- CVM 60.9M
- IPO Year
- MDAI N/A
- CVM 1987
- Fundamental
- Price
- MDAI $2.13
- CVM $7.09
- Analyst Decision
- MDAI Strong Buy
- CVM
- Analyst Count
- MDAI 1
- CVM 0
- Target Price
- MDAI $3.50
- CVM N/A
- AVG Volume (30 Days)
- MDAI 868.8K
- CVM 97.4K
- Earning Date
- MDAI 11-11-2025
- CVM 08-14-2025
- Dividend Yield
- MDAI N/A
- CVM N/A
- EPS Growth
- MDAI N/A
- CVM N/A
- EPS
- MDAI N/A
- CVM N/A
- Revenue
- MDAI $27,549,000.00
- CVM N/A
- Revenue This Year
- MDAI N/A
- CVM N/A
- Revenue Next Year
- MDAI $60.05
- CVM N/A
- P/E Ratio
- MDAI N/A
- CVM N/A
- Revenue Growth
- MDAI 22.27
- CVM N/A
- 52 Week Low
- MDAI $1.01
- CVM $1.98
- 52 Week High
- MDAI $3.25
- CVM $32.70
- Technical
- Relative Strength Index (RSI)
- MDAI 44.61
- CVM 34.49
- Support Level
- MDAI $2.07
- CVM $6.06
- Resistance Level
- MDAI $2.27
- CVM $9.35
- Average True Range (ATR)
- MDAI 0.19
- CVM 0.70
- MACD
- MDAI -0.04
- CVM -0.30
- Stochastic Oscillator
- MDAI 7.61
- CVM 24.64
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.